Search results
Down -25.53% in 4 Weeks, Here's Why You Should You Buy the Dip in Regenxbio (RGNX)
Zacks via Yahoo Finance· 4 months agoRegenxbio (RGNX) is technically in oversold territory now, so the heavy selling pressure might have...
REGENXBIO's (RGNX) Hunter Syndrome Study Meets Goal, Stock Up
Zacks via Yahoo Finance· 3 months agoREGENXBIO (RGNX) gains 12% on positive top-line results from the phase I/II/III study of its...
REGENXBIO Inc.'s (NASDAQ:RGNX) recent 7.9% pullback adds to one-year year losses, institutional...
Simply Wall St. via Yahoo Finance· 1 month agoKey Insights Significantly high institutional ownership implies REGENXBIO's stock price is sensitive...
Regenxbio (RGNX) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoRegenxbio (RGNX) delivered earnings and revenue surprises of -9.72% and 25.56%, respectively, for...
Regenxbio Inc (RGNX) President and CEO Kenneth Mills Sells 15,000 Shares
GuruFocus.com via Yahoo Finance· 2 months agoRegenxbio Inc (NASDAQ:RGNX), a biotechnology company focused on the development, commercialization,...
Earnings Preview: Regenxbio (RGNX) Q2 Earnings Expected to Decline
Zacks via Yahoo Finance· 2 years agoRegenxbio (RGNX) doesn't possess the right combination of the two key ingredients for a likely...
REGENXBIO (NASDAQ:RGNX) adds US$111m to market cap in the past 7 days, though investors from five...
Simply Wall St. via Yahoo Finance· 6 months agoREGENXBIO Inc. (NASDAQ:RGNX) shareholders should be happy to see the share price up 16% in the last...
Despite Solid Efficacy From Gene Therapy, This Analyst Cuts REGENXBIO's Price Target
Benzinga via Yahoo Finance· 2 years agoOn Monday, REGENXBIO Inc (NASDAQ: RGNX) announced a program update from its ongoing clinical...
REGENXBIO Inc. (NASDAQ:RGNX) Analysts Are More Bearish Than They Used To Be
Simply Wall St. via Yahoo Finance· 1 year agoThe latest analyst coverage could presage a bad day for REGENXBIO Inc. (NASDAQ:RGNX), with the...
Even after rising 26% this past week, REGENXBIO (NASDAQ:RGNX) shareholders are still down 48% over...
Simply Wall St. via Yahoo Finance· 2 years agoThis month, we saw the REGENXBIO Inc. (NASDAQ:RGNX) up an impressive 31%. But that cannot eclipse...